- Home
- PVBC vs XBIT Comparison
PVBC vs XBIT Comparison
Compare PVBC & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVBC
- XBIT
- Stock Information
- Founded
- PVBC 1913
- XBIT 2005
- Country
- PVBC United States
- XBIT United States
- Employees
- PVBC N/A
- XBIT N/A
- Industry
- PVBC Major Banks
- XBIT Pharmaceuticals and Biotechnology
- Sector
- PVBC Finance
- XBIT Health Care
- Exchange
- PVBC Nasdaq
- XBIT Nasdaq
- Market Cap
- PVBC 184.9M
- XBIT 203.2M
- IPO Year
- PVBC 2015
- XBIT 2015
- Fundamental
- Price
- PVBC $11.16
- XBIT $6.62
- Analyst Decision
- PVBC Hold
- XBIT
- Analyst Count
- PVBC 1
- XBIT 0
- Target Price
- PVBC $12.00
- XBIT N/A
- AVG Volume (30 Days)
- PVBC 39.3K
- XBIT 57.1K
- Earning Date
- PVBC 10-24-2024
- XBIT 11-13-2024
- Dividend Yield
- PVBC N/A
- XBIT N/A
- EPS Growth
- PVBC N/A
- XBIT N/A
- EPS
- PVBC 0.32
- XBIT N/A
- Revenue
- PVBC $55,219,000.00
- XBIT N/A
- Revenue This Year
- PVBC N/A
- XBIT N/A
- Revenue Next Year
- PVBC $4.77
- XBIT N/A
- P/E Ratio
- PVBC $34.71
- XBIT N/A
- Revenue Growth
- PVBC N/A
- XBIT N/A
- 52 Week Low
- PVBC $7.36
- XBIT $3.54
- 52 Week High
- PVBC $12.32
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- PVBC 58.36
- XBIT 41.68
- Support Level
- PVBC $10.86
- XBIT $6.36
- Resistance Level
- PVBC $11.08
- XBIT $7.43
- Average True Range (ATR)
- PVBC 0.28
- XBIT 0.50
- MACD
- PVBC 0.01
- XBIT -0.10
- Stochastic Oscillator
- PVBC 62.37
- XBIT 13.27
About PVBC Provident Bancorp Inc. (MD)
Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.